ANI Pharmaceuticals Inc
NASDAQ:ANIP

Watchlist Manager
ANI Pharmaceuticals Inc Logo
ANI Pharmaceuticals Inc
NASDAQ:ANIP
Watchlist
Price: 57.79 USD 0.91% Market Closed
Market Cap: 1.2B USD

Intrinsic Value

The intrinsic value of one ANIP stock under the Base Case scenario is 111.96 USD. Compared to the current market price of 57.79 USD, ANI Pharmaceuticals Inc is Undervalued by 48%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ANIP Intrinsic Value
111.96 USD
Undervaluation 48%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
ANI Pharmaceuticals Inc

Valuation History Unavailable

Historical valuation for ANIP cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about ANI Pharmaceuticals Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
ANI Pharmaceuticals Inc

Current Assets 536.3m
Cash & Short-Term Investments 155.2m
Receivables 220.3m
Other Current Assets 160.8m
Non-Current Assets 756.1m
PP&E 58.2m
Intangibles 599.2m
Other Non-Current Assets 98.8m
Efficiency

Free Cash Flow Analysis
ANI Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
ANI Pharmaceuticals Inc

Revenue
811.5m USD
Cost of Revenue
-323.2m USD
Gross Profit
488.3m USD
Operating Expenses
-459.2m USD
Operating Income
29m USD
Other Expenses
-35.5m USD
Net Income
-6.4m USD
Fundamental Scores

ANIP Profitability Score
Profitability Due Diligence

ANI Pharmaceuticals Inc's profitability score is 52/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
ROE is Increasing
Exceptional 1-Year Revenue Growth
52/100
Profitability
Score

ANI Pharmaceuticals Inc's profitability score is 52/100. The higher the profitability score, the more profitable the company is.

ANIP Solvency Score
Solvency Due Diligence

ANI Pharmaceuticals Inc's solvency score is 37/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Average D/E
Average Altman Z-Score
37/100
Solvency
Score

ANI Pharmaceuticals Inc's solvency score is 37/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ANIP Price Targets Summary
ANI Pharmaceuticals Inc

Wall Street analysts forecast ANIP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ANIP is 83.06 USD with a low forecast of 65.65 USD and a high forecast of 98.7 USD.

Lowest
Price Target
65.65 USD
14% Upside
Average
Price Target
83.06 USD
44% Upside
Highest
Price Target
98.7 USD
71% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

ANI Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for ANIP is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

ANIP Insider Trading
Buy and sell transactions by insiders

ANIP News

What is the Intrinsic Value of one ANIP stock?

The intrinsic value of one ANIP stock under the Base Case scenario is 111.96 USD.

Is ANIP stock undervalued or overvalued?

Compared to the current market price of 57.79 USD, ANI Pharmaceuticals Inc is Undervalued by 48%.

Back to Top